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C BY-NC-Abstract The Quantitative structure–activity relationship (QSAR) analyses were carried out for a
series of imidazolinones as nonpeptide angiotensin II receptor antagonists to ﬁnd out the structural
requirements of their antihypertensive activities. Partial Least Squares Regression (PLSR) method
coupled was applied to derive QSAR models which were further validated for statistical signiﬁcance
and predictive ability by internal and external validation. The statistically signiﬁcant best model
with high correlation coefﬁcient (r2 = 0.9031) was selected for further study. The model was further
validated by means of crossed squared correlation coefﬁcient (q2 = 0.8652 and pred_r2 = 0.8261)
which shows the model has good predictive ability, higher value of F statics 66.831 also validates
signiﬁcance of model, Degree of freedom20. The physicochemical descriptor SssCH2count and
alignment-independent descriptors T_N_O_6, T_2_Cl_6 and Chi5 were found to show signiﬁcant
correlation with biologic activity in imidazolinones. Successful implementation of a predictive
QSAR model largely depends on the selection of a preferred set of molecular descriptors that
can signify the antihypertensive new design molecules.
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ND license.1. Introduction
The rennin–angiotensin system (RAS) plays a major role in the
regulation of blood pressure and electrolyte homeostasis (Gil-
man et al., 1985). Rennin–angiotensin system is a cascade of
proteolytic enzymes (renin and angiotensin converting enzyme
(ACE)) that results in the production of the systemic hormone
angiotensin II (Ang II). The blockade of RAS with inhibitors
of ACE has demonstrated the effectiveness of the reduction of
levels of Ang II on cardiovascular and kidney hemodynamics,
aldosterone production and release, and the absorption of so-
dium. Antagonists of Ang II constitute an alternative method
220 M.C. Sharma et al.blocking the RAS. Several peptidic and nonpeptidic Ang II
receptor antagonists are known. The therapeutic availability
is less for the peptidic Ang II antagonist due to their poor
bioavailability; short plasma half-life and partial agonist activ-
ity but the nonpeptidic Ang II receptor antagonist lacks the
defect of the peptidic antagonist (Smith et al., 1992). Renin,
an enzyme produced primarily by the juxtaglomerular cells
of the kidney, catalyzes the conversion of angiotensinogen into
an inactive substance, angiotensin I (Ang-I). Angiotensin-
converting enzyme (ACE) then converts Ang-I to the
physiologically active angiotensin II which causes potent vaso-
constriction, aldosterone secretion and sympathetic activation.
Angiotensin II also facilitates the release of antidiuretic
hormone (ADH) from neurohypophysis and thirst receptors,
thus adding to volumes and vasopressor factors in some
conditions of hypertension and CHF. It also is a putative
neurotransmitter in the central nervous system (CNS). The
action of angiotensin II is mediated through selective mem-
brane-bound angiotensin II receptors type 1 (AT1) and type
2 (AT2). These receptors have been identiﬁed and belong to
the G protein-coupled receptor super family (GPCRs). All of
these actions contribute to the development of hypertension
(Messerli et al., 1996; Goodfriend et al., 1996; Bauer and
Reams, 1996). The discovery of potent and orally active non-
peptide Ang II antagonists such as losartan and eprosartan
has encouraged the development of a large number of similar
compounds (Jin et al., 2007). Among them, irbesartan, cande-
sartan, valsartan, telmisartan, tasosartan, and olmesartan areTable 1 Structures and biological activity data and structures of th
N
R1 O
R3
R2
N
N HN
N
Compound-1-11
R1
Compound R1 R2
1 Phenyl Phenyl
2a Methyl Phenyl
3 n-Propyl Phenyl
4 n-Propyl CF3
5 n-Propyl CH3
6a n-Propyl –(CH2)2
7 n-Propyl –(CH2)4
8 n-Butyl –(CH2)4
9a n-Propyl –(CH2)5
10 n-Propyl –(CH2)2–S–(CH2)2
11 n-Propyl –(CH2)2–O–(CH2)2
12a n-Propyl CH3
13 n-Propyl –(CH2)2–S–(CH2)2
14 n-Propyl –(CH2)4
15 n-Butyl –(CH2)4
a Test compound.on the market (Wexler et al., 1996). Computational chemistry
has developed into an important contributor to rational drug
design. Quantitative structure activity relationship (QSAR)
modeling results in a quantitative correlation between chemi-
cal structure and biological activity. The QSAR approach
helps to correlate the speciﬁc biological activities or physical
properties of a series of compounds with the measured or com-
puted molecular properties of the compounds, in terms of
descriptors (Hansch, 1969; Doweyko, 2008). A number of
quantitative structure–activity relationship (QSAR) studies re-
lated to the design of angiotensin II receptor antagonists drugs
have also been reported (Belvisi et al., 1996; Datar et al., 2004;
Kurup et al., 2001;Sharma et al., 2009). In the present study, to
gain insight into the structural and molecular requirement
inﬂuencing the Angiotensin II receptor antagonistic activity;
herein we depict QSAR analysis of some Imidazolinones deriv-
atives for Angiotensin II receptor antagonistic activity. In the
present study, the IC50 was used to establish a classical linear-
classiﬁcation based QSAR equation. The results obtained may
contribute to further designing novel antihypertensive agents.2. Experimental
2.1. Data set for analysis
To obtain mathematical expressions able to discriminate be-
tween good (high) and moderate-low activity compounds,e compounds in the series.
N
O
R3
R2
SO2NHCOPh
Compound-12-15
R3 IC50 (nM) logIC50
Phenyl 1400 3.146
Phenyl 100 2.000
Phenyl 300 2.477
CF3 20 1.301
CH3 4.0 0.6021
– 3.0 0.4771
– 0.9 –0.0457
– 0.9 0.0457
– 3.0 0.4771
– 2.0 0.3012
– 8.0 0.9031
CH3 3.0 0.4771
– 1.0 0.0000
– 9.0 0.954243
– 1.0 0.0000
Table 2 Descriptors used in QSAR model with value.
chi5 SssCH2 count H Count T_C_N_7 SsCH3 count T_2_Cl_6 T_N_O_6 SssCH2E-index
14.1855 3.2507 4.1609 129.2345 49.878 25 35 27.0460
14.5820 3.4571 4.5584 133.8515 51.714 26 36 28.0215
14.9784 3.9074 4.9411 138.4685 53.551 27 37 28.9940
14.1426 2.5527 3.7708 124.6175 48.021 24 34 26.0740
15.2891 5.5431 5.3312 140.3112 55.383 28 38 25.7854
15.3320 2.4782 3.7623 143.0855 50.683 28 38 29.9776
15.6855 4.8078 5.7213 147.7025 57.258 29 39 30.9470
12.6587 3.3284 4.5518 133.8515 59.653 26 36 23.9854
14.8926 3.0743 3.7656 123.7648 51.714 26 36 28.0193
15.3320 4.3068 5.9865 132.6538 55.985 28 38 29.9775
14.8926 3.4575 4.5514 133.8515 39.684 26 36 28.0193
16.3650 4.1018 5.1871 145.4485 56.501 30 41 29.5438
12.4367 3.4657 2.4576 119.548 45.643 25 35 27.0460
13.3566 12.230 10.141 20.0798 12.076 44 54 24.69971
16.7189 15.387 13.131 25.7268 15.716 21 66 36.56250
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pounds, with and without the desired biological proﬁle, must
be statistically processed. In the present study, the angiotensin
II receptor antagonist’s activity was used to establish a classi-
cal linear-classiﬁcation-based QSAR equation. Taking into ac-
count that the most critical aspect, in the construction of a
training dataset, is the molecular diversity of the included com-
pounds, we had selected compounds having as much structural
variability as possible. A data set of ﬁfteen compounds of Imi-
dazolinones for angiotensin II receptor antagonists was used
for the present QSAR study (Quan et al., 1994). There is high
structural diversity and a sufﬁcient range of the biological
activity in the selected series of these derivatives (Table 1). It
insists as to select these series of compounds for our QSAR
studies. The biological activity values [IC50 (nM)] for angioten-
sin II receptor antagonists reported in literature were con-
verted to their molar units and then further to negative
logarithmic scale (log IC50) and subsequently used as the
dependent variable for the QSAR analysis. The molecular
modeling calculations were performed using the Molecular De-
sign Suite (MDS) 3.5 (http://.www.vlifesciences.com). Each
compound was energy minimized and batch optimized by
using Merck Molecular Force Field (Halgren and Nachbar,
1996) force ﬁeld and Gasteiger–Marsili (Gasteiger and Marsili,
1980) charges followed by AM1 (Austin Model-1) Hamiltonian
method available in MOPAC module with the convergence cri-
terion 0.001 kcal/mol A˚. ﬁxing Root Mean Square Gradients
(RMS) to 0.01 kcal/mol A˚. The chemical information con-
tained in a great number of compounds, with and without
the desired biological proﬁle, must be statistically processed.
Hence, all the molecules were constructed using the standard
geometry with the 2D molecular module of MDS.
2.2. Molecular descriptors for QSAR analysis
A large number of MDS is usually used in QSAR methods.
Thermodynamic parameters describe free energy change dur-
ing drug receptor complex formation. Spatial parameters are
the quantiﬁed steric features of drug molecules required for
its complimentary ﬁt with receptor. The hydrophobic proper-
ties express the ability of a molecule to be transported through
the organism to interact with biological membranes and to bebound to the receptor by van der Waal’s forces. The descrip-
tors selected for modeling inhibitory activity of the Imidazoli-
nones derivatives are summarized in Table 2. The random
selection method was used for training data selection at
around 80% of total number of compounds and variable selec-
tion was performed by methodology. We considered as hydro-
phobic descriptor the decimal logarithm of the octanol–water
partition coefﬁcient (slogP). They deﬁne the ability of the drug
to join to the receptor. The energy-minimized geometry was
used for the calculation of the various 2D descriptors (Individ-
ual, Chi, ChiV, Path count, ChiChain, ChiVChain, Chainpath-
count, Cluster, Pathcluster, Kapa, Element Count, Estate
number, Estate contribution, Semi-impirical, Hydophillic–
hydophobic, Polar surface area and Alignment independent)
and was considered as independent variables in the present
study (Table 2). The preprocessing of the independent vari-
ables (i.e., descriptors) was done by removing the invariable
(constant column), which resulted in total 265 descriptors to
be used for QSAR analysis. The sphere exclusion (SE) method
(Golbraikh and Tropsha, 2002) was adopted for division of
training and test data set comprising of 11 and 4 molecules,
respectively, with dissimilarity value of 4.5 where the dissimi-
larity value gives the sphere exclusion radius. In classical
sphere-exclusion algorithm the molecules are selected whose
similarities with each of the other selected molecules are not
higher than a deﬁned threshold. Each selected molecule gener-
ates a hyper-sphere around itself, so that any molecule inside
the sphere is excluded from the selection in the train set and
driven toward the test set. The number of compounds selected
and the diversity among them can be determined by adjusting
the radius of the sphere (R).
2.3. Statistical analysis
Three signiﬁcant statistical models were generated, by using
partial least square analysis method. The cross-validation anal-
ysis was performed using the leave-one-out method. In the se-
lected equations, the cross-correlation limit was set at 0.5, the
number of variables at 10, and the term selection criteria at r2.
An F value was speciﬁed to evaluate the signiﬁcance of a var-
iable. The higher the F value, the more stringent was the signif-
icance level: F test ‘‘in’’ as 4 and F test ‘‘out’’ as 3.99. The
Table 3 Unicolumn statistics of the training and test sets.
Data set Average (mean) Max. Min. Std. Dev Sum
Training 13.743 10.543 8.321 1.874 121.475
Test 8.6543 6.7564 5.3217 0.6532 65.7532
222 M.C. Sharma et al.variance cut-off was set at 0 and scaling was auto scaling in
which the number of random iterations was set at 100. The fol-
lowing statistical parameters were considered for comparison
of the generated QSAR models: correlation coefﬁcient (r),
squared correlation coefﬁcient (r2), predictive r2 for external
test set (pred r2) for external validation, and Fischer’s value
(F).
pred r2 ¼ 1
Pðyi  y^Þ2
Pðyi  ymeanÞ2
where yi, and yˆi are the actual and predicted activity of the ith
molecule in the test set, respectively, and ymean is the average
activity of all molecules in the training set. The robustness of
the selected model is checked by Y – randomization test. The
robustness of the models for training sets is examined by com-
paring these models to those derived for random datasets.
Random sets are generated by rearranging the activities of
the molecules in the training set. The regression coefﬁcient r2
is a relative measure of ﬁt by the regression equation. It repre-
sents the part of the variation in the observed data that is ex-
plained by the regression. Internal validation is carried out
using ‘leave-one-out’ (LOO) method (Cramer et al., 1988).
The cross-validated coefﬁcient, q2, is calculated using the fol-
lowing equation:
q2 ¼ 1
Pðyi  y^Þ2
Pðyi  ymeanÞ2
where yi, and yˆi are the actual and predicted activity of the ith
molecule in the training set, respectively, and ymean is the aver-
age activity of all molecules in the training set. However, a
high q2 value does not necessarily give a suitable representation
of the real predictive power of the model for antihypertensive
ligands. So, an external validation is also carried out in the
present study. The external predictive power of the model is as-
sessed by predicting pIC50 value of the four test set molecules,
which are not included in the QSAR model development. The
predictive ability of the selected model is also conﬁrmed by
pred_r2 or rCVext2. The signiﬁcance of the models hence ob-
tained is derived based on a calculated Z score (Zheng and
Tropsha, 2000). Zscore value is calculated by the following
formula:
Zscore ¼ h lr
where h is the q2 value calculated for the actual dataset, l the
average q2, and r is its standard deviation calculated for vari-
ous iterations using models built by different random datasets.
2.4. QSAR by partial least squares (PLS) regression method
Partial Least Squares (PLS) Regression Method is an effective
technique for ﬁnding the relationship between the properties of
a molecule and its structure. In mathematical terms, PLS re-
lates a matrix Y of dependent variables to a matrix X of molec-
ular structure descriptors, i.e., a latent variable approach to
modeling the covariance structures in these two spaces. PLS
has two objectives: to approximate the X and Y data matrices,
and to maximize the correlation between them. Whereas the
extraction of PLS components is performed stepwise and the
importance of a single component is assessed independently,
a regression equation relating each Y variable with the X ma-trix is created. PLS decomposes the matrix X into several la-
tent variables that correlate best with the activity of the
molecules. PLS can be done using NIPALS or SIMPLS itera-
tive algorithm, with consecutive estimates obtained using the
residuals from previous iterations as the new dependent vari-
able (Wold et al., 1984). This ensures that the QSAR models
are selected based on their ability to predict the data rather
than to ﬁt the data (Kulkarni and Kulkarni, 1999).
Since detailed descriptions of the PLS method are available
in many standard literature, a brief outline is given here. Inde-
pendent data X are decomposed into a score matrix T, a load-
ing matrix P+ and an error matrix E.
X ¼ TP! þþE
Similarly, dependent data Y are decomposed into a score ma-
trix U and a loading matrix C! and the error term F.
Y ¼ UC! þ F
These two equations are called outer relations. The goal of the
PLS algorithm is to minimize the norm of F while keeping the
correlation between X and Y by an inner relation.
U ¼ BT3. Results and Discussion
The QSAR study of thirteen derivatives for antihypertensive
activity (Table 1) through PLSR methodology, using VLife
MDS 3.5 software resulted in the following statistically signif-
icant models, considering the term selection criterion as r2, q2
and pred_r2. The training and test set molecules for this group
of compounds were selected by sphere exclusion method and
the models were validated by both internal and external valida-
tion procedure. The sphere exclusion method was used to cre-
ate the training and test sets from the data. This rational
selection method took into consideration both biologic and
chemical space for division of the data set. The unicolumn sta-
tistics were the training and test sets with a dissimilarity value
of 4.5 as reported in (Table 3). The dissimilarity value gives the
sphere exclusion radius. The unicolumn statistical analysis can
be interpreted to mean that the standard deviation of the train-
ing set is higher than that of the test set, indicating that there is
a wide spread of activity in the training set with respect to the s
mean compared with the test set. This observation showed that
test set was interpolative and derived within the minimum–
maximum range of training set. The mean and standard
deviation of pIC50 values of sets of training and test provide
insights to relative difference of mean and point density distri-
bution of two sets. The mean of the test sets was higher than
the train sets which indicates the presence of relatively more
active molecules as compared to the inactive ones. To ensure
a fair comparison, the same training and test sets were used
for each model’s development.
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log IC50 =+1.2865 (SssCH2count) +2.3578 (T_2_Cl_6) +
0.4927(T_N_O_6) + 3.1654(Chi5) +3.6527 Ntraining = 11,
Ntest = 4, Degree of freedom= 20, r
2 = 0.9031,
q2 = 0.8652, F test = 66.831, r2_se = 0.1426, q
2
_se = 0.4375,
pred_r2 = 0.8261, pred_r2se = 3.43765.
The derived model shows good correlation between biologi-
cal activity and parameters SssCH2count, T_2_Cl_6, T_N_O_6,
and Chi5 as the correlation coefﬁcient r= 0.9031. The model-1
fulﬁlls the selection criteria’s like correlation coefﬁcient r2 > 0.8
for activity with low standard error of squared correlation coef-
ﬁcient r2_se < 0.3 (0.1426) show the relative good ﬁtness of the
model and F value >11 times than tabulated F value show the
99% statistical signiﬁcance of the regression model. The valida-
tion criteria for selection of the model are cross validated
squared correlation coefﬁcient q2 > 0.8 (0.8652) for trainingTable 4 Comparative observed and predicted activities
(LOO) of QSAR models.
Compound Observed
activity
Predicted
activity 1
Predicted
activity 2
Predicted
activity 3
1 3.14 3.22 2.97 2.89
2 2.00 1.89 2.18 1.74
3 2.47 2.59 2.32 2.21
4 1.30 1.39 1.16 1.11
5 0.60 0.53 0.81 0.76
6 0.47 0.31 0.29 0.86
7 0.04 0.018 0.026 0.22
8 0.045 0.019 0.064 0.026
9 0.477 0.494 0.459 0.484
10 0.301 0.322 0.284 0.319
11 0.903 0.887 0.879 0.927
12 0.477 0.459 0.494 0.443
13 0.000 0.005 0.078 0.015
14 0.954 0.960 0.938 0.946
15 0.000 0.009 0.0021 0.093
Table 5 Correlation matrix indicating inter-correlation
between descriptors for model-1.
pIC50 SssCH2count T_2_Cl_6 T_N_O_6 Chi5
pIC50 1
SssCH2count 0.8437 1
T_2_Cl_6 0.3754 0.6938 1
T_N_O_6 0.2476 0.5873 0.8045 1
Chi5 0.3709 0.5288 0.7842 0.9243 1
Table 6 Correlation matrix indicating inter-correlation between de
pIC50 H count
pIC50 1
H count 0.5321 1
T_2_Cl_6 0.3983 0.6423
T_C_N_7 0.2487 0.4376
Rotatable bond count 0.1764 0.3218set and pred_r2 > 0.40 (0.8261) for test set. However, a high
q2 value does not necessarily give a suitable representation of
the real predictive power of the model for Ang II ligands. So,
an external validation was also carried out in the present study.
Theobserved andpredictedlog IC50 alongwith residual values
and Correlation matrix are shown in Tables 4 and 5. The model
incorporates four parameters SssCH2count, T_2_Cl_6,
T_N_O_6, and Chi5 their corresponding values for each mole-
cule in the selected model. The descriptor SssCH2count in the
model represents the electro-topological state indices for num-
ber of –CH2 group connected with two double single bonds.
The positive correlation suggests that angiotensin II activity imi-
dazolinones derivativesmay be increased by increasing the num-
ber of such –CH2groups present in themolecules. Further itmay
be inferred that increasing the saturation of the aromatic rings
will contribute to increase Ang II activity. As a positive contrib-
uting descriptor, T_2_Cl_6 is an alignment-independent
descriptor inﬂuencing activity variation and is directly propor-
tional to activity. The descriptor T_2_Cl_6 is the number of dou-
ble-bonded atoms separated from the chlorine atom by six
bonds. It is another inﬂuential alignment-independent descrip-
tor suggesting that the presence of substituents with chlorine
on the imidazole ring at the ortho position will lead to an in-
crease in activity. The descriptor T_N_O_6 is the number of
atoms separated from the nitrogen atomby six bonds, indicating
that the presence of substituents with nitrogen atoms (e.g., –
NO2, –N (CH3)2, –NHCOCH3, NHCOCH2CH3) at the phenyl
ring in the ortho position will lead to a positive effect on the
activity. Chi5 is a molecular connectivity index descriptor.
Molecular connectivity, a quantiﬁcation of topology, is detri-
mental to biologic activity in the aforementioned models. The
model is validated by a_ran_r2 = 0.00021, a_ran_q2 = 0.001,
a_ran_pred_r2 = 0.000432, best_ran_r2 = 0.2875, be-
st_ran_q2 = 0.3265, Z score_ran_r2 = 5.3765 and Z score_r-
an_q2 = 7.3265. The randomization test suggests that the
developedmodel has a probability of less than 1% that themod-
el is generated by chance. The observed and predictedlog IC50
along with residual values and Correlation matrix are shown in
Tables 4 and 5.
3.2. Model-2
log IC50= +1.2865 (Hydrogen Count) +1.3578 (T_2_Cl_6)
+ 0.4927(T_C_N_7) + 3.1654(Rotatable Bond Count)
+3.6527Ntraining= 11, N test= 4, Degree of freedom = 21,
r2 = 0.8643, q2 = 0.7643, F test = 58.213, r2_se = 0.2155,
q2_se = 0.1822, pred_r
2 = 0.8032, pred_r2se = 2.1654.
The statistically best signiﬁcant model (Model 2) obtained
by the shows 86.43% variance in the observed activity values.
The low standard error of r2_se = 0.2158 demonstrates
accuracy of the model. The F test value, 58.213 shows thescriptors for model-2.
T_2_Cl_6 T_C_N_7 Rotatable bond count
1
0.6864 1
0.6807 0.8632 1
Table 7 Correlation matrix indicating inter-correlation
between descriptors for model-3.
pIC50 SsCH3count SssCH2E-index T_C_N_7
pIC50 1
SsCH3count 0.8742 1
SssCH2E-index 0.5175 0.7138 1
T_C_N_7 0.3987 0.5877 0.9035 1
224 M.C. Sharma et al.overall statistical signiﬁcance level to be 99.99% of the model,
which means that the probability of failure for model is 1 in
10,000. Cross validated q2 of this model, 0.7643, indicates goodFigure 1 Correlation plots of observed and predictivity activinternal prediction power of the model. Another parameter for
predictivity of test set compounds is high pred_r2 = 0.8032,
which shows good external predictive power of the model
and degree of freedom 21. The model is validated by
a_ran_r2 = 0.00421, a_ran_q2 = 0.001, a_ran_pred_r2 =
0.0001, best_ran_r2 = 0.1764, best_ran_q2 = 0.0653, Z scor-
e_ran_r2 = 3.1542 and Z score_ran_q2 = 6.4376. The Hydro-
gen Count descriptor is a type of element count descriptor
showing the number of hydrogen atoms in a compound,
suggesting double, triple, or aromatic substituents over alkyl
substituents. T_2_Cl_6 is another inﬂuential alignment-inde-
pendent descriptor suggesting that the presence of substituents
with chlorine on the phenyl ring at the ortho position will leadities of the training and test compound models 1, 2 and 3.
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ment-dependent descriptor signifying the number of carbon
atoms (single-, double-, or triple-bonded) separated from any
nitrogen atom (single- or double-bonded) by seven bond dis-
tances in a molecule. It suggests that the mono substituent with
a carbon atom in the position of the imidazole ring is detri-
mental to activity. The last descriptor Rotatable Bond Count
refers to number of rotatable bonds in the molecules. The
slightly positive term associated with the descriptor in QSAR
model indicates that fractional increase in the rotatable bonds
in the molecule is beneﬁcial for Ang II activity. The observed
and predicted log IC50 along with residual values and Corre-
lation matrix are shown in Tables 4 and 6.
3.3. Model-3
log IC50 =+1.5327 (SsCH3count)  0.9542 (SssCH2E-
index) + 0.4927(T_C_N_7) + 1.5423Ntraining = 11, Ntest =
4, Degree of freedom= 20, r2 = 0.8365, q2 = 0.7265, F
test = 50.321, r2_se = 0.3097, q
2
_se = 0.2952, pred_r
2 =
0.7058, pred_r2se = 0.1754.
Following statistically signiﬁcant models, considering the
term selection criteria as r2. The statistically signiﬁcant model
(Model 3) with coefﬁcient of determination (r2) = 0.8365
(which corresponds to value of r2se = 0.3097) was considered
as a model for antihypertensive. The model showed an internal
predictive power (q2 = 0.7265 of 72% and predictivity for
external test set (pred_r2 = 0.7058) about 70%. The F test va-
lue, 50.321 shows the overall statistical signiﬁcance level to be
99.99% of the model, which means that the probability of fail-
ure for model is 1 in 10,000.SsCH3count, classiﬁed as estate
numbers (i.e., the descriptor that signiﬁes the total number
of methyl groups connected with a single bond) contributed
negatively (25%) in the mathematical representation of the
model. Another parameter, SssCH2E-index, which signiﬁes es-
tate contributions deﬁning electroto-pologic state indices for
the number of CH2 groups attached with two single bonds,
also showed a negative contribution. The descriptor
T_C_N_7 is an alignment-dependent descriptor signifying the
number of carbon atoms (single-, double-, or triple-bonded)
separated from any nitrogen atom (single- or double-bonded)
by seven bond distances in a molecule. It suggests that the
mono substituent with a carbon atom in the position of the
imidazole ring is detrimental to activity. The observed and pre-
dicted log IC50 along with residual values and Correlation
matrix are shown in Tables 4 and 7.
4. Conclusion
The 2D QSAR studies were conducted with a series of angio-
tensin II antagonists, and some useful molecular models were
obtained. The physicochemical and alignment-independent
descriptors were found to have an important role in governingthe change in activity. The regression equation so obtained will
be useful for the prediction of biological activities of the
designed series of compounds, in future. The good correlation
between experimental and predicted biological activity for four
compounds in the test set further highlights the reliability of
the constructed QSAR model (Fig. 1).Acknowledgments
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